Evidence map›Paper›PMID 40213526›Full record

ArticleGynecologic oncology reports2025

Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report.

Katie Foug, Stephanie L Skala, Erica Stien, Kevin Reynolds, Jean Siedel, Shitanshu Uppal

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katie FougUniversity of Michigan, School of Medicine, Ann Arbor, MI, United States.
Stephanie L SkalaMichigan Medicine, Department of Pathology, Ann Arbor, MI, United States.
Erica StienMichigan Medicine, Department of Radiology, Ann Arbor, MI, United States.
Kevin ReynoldsMichigan Medicine, Department of Gynecology Oncology, Ann Arbor, MI, United States.
Jean SiedelMichigan Medicine, Department of Gynecology Oncology, Ann Arbor, MI, United States.
Shitanshu UppalMichigan Medicine, Department of Gynecology Oncology, Ann Arbor, MI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PARP inhibitorRecurrent diseaseSomatic BRCA mutationUterine adenosarcoma

Identifiers

PMID40213526
PMCPMC11982467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.